Advanced search
Publication Cover
Artificial Cells, Blood Substitutes, and Biotechnology Volume 39, 2011 - Issue 3
Journal homepage
913
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Polyhemoglobin-superoxide Dismutase-catalase-carbonic Anhydrase: A Novel Biotechnology-based Blood Substitute that Transports both Oxygen and Carbon Dioxide and also Acts as an Antioxidant

Yuzhu Bian Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
,
Zhixia Rong Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
&
Thomas Ming Swi Chang Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaCorrespondence[email protected]
Pages 127-136 | Published online: 17 May 2011

REFERENCES

  • Chang, T. M. S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials Vol. 1. Basel: Karger Landes Systems.
  • Chang, T.M.S. (2007). Artificial Cells: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/StemCell Therapy. Singapore: World Science Publishers/Imperial College Press.
  • Winslow, R. M. (2005). Blood Substitutes. London: Elsevier Inc.
  • Chang, T. M. S. (1964). Semipermeable microcapsules. Science 146: 524–525.
  • Chang, T. M. S. (1971). Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem Biophys Res Commun 44: 1531–1533.
  • Gould, S. A. . (2002). The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 195: 445–452.
  • Levy, J. H. . (2002). Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 124 (1): 35–42.
  • Geers, C., Gros, G. (2000). Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Reviews 80 (2): 681–715.
  • Arthurs, G. J., Sudhakar, M. (2005). Carbon dioxide transport. Cont Ed Anaesth 5 (6): 207–210.
  • Bauer, C., Gros, G., Bartels, H.. (1980). Biophysics and Physiology of Carbon Dioxide, Symposium Held at the University of Regensburg (FRG), April 17–20, 1979. New York: Springer-Verlag.
  • Monanty, A. K., Kannan, K. K., Mahajan, S. K. (1998). Human carbonic anhydrase I: Effects of specific site mutations on its function. J. Biosci 3: 235–246.
  • Lindskog, S. (1997). Structure and mechanism of carbonic anhydrase. Pharmacol Ther 74 (1): 1–20.
  • D'Agnillo, F., Chang, T. M. S. (1998). Polyhemoglobin-superoxide dismutase, catalase as a blood substitute with antioxidant properties. Nature Biotechnol 16: 667–671.
  • Henry, R. P. (1991). Techniques for measuring carbonic anhydrase activity in vitro. Dodgson S. J., Tashian R. E., Gros G., Carter N. D. The Carbonic Anhydrases. New York: Plenum Press, 119–126.
  • Wilbur, K. M., Anderson, N. G. (1948). Electrometric and colorimetric determination of carbonic anhydrase. J Biol Chem 176: 147–154.
  • Zhu, H.L., Du, Q.Q., Chen, C., Chang, T.M.S. (2010). The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate. Artificial Cells, Blood Substitutes, and Biotechnology, 38: 57–63.
  • Guyton, A. C., Hall, J. E. (2000). Textbook of Medical Physiology, 10th. Philadelphia: W. B. Saunders Company, 1–1064.
  • Philpot, F. J., Philpot, J. St. L. (1937). A modified colorimetric estimation of carbonic anhydrase. Biochem J 30 (12): 2191–2193.
  • Hlastala, M. P., Berger, A. J. (2001). Physiology of Respiration, 2nd. New York: Oxford University Press, 1–275.
  • Chang, T. M. S. (2010). Blood replacement with engineered hemoglobin and hemoglobin nanocapsules. Wiley Interdisciplinary Reviews on Nanomedicine and Nanobiotechnology 2: 418–430.
  • Chang, T.M.S. (2009). Nanobiotechnology for hemoglobin based blood substitutes. Critical Care Clinics 25: 373–382.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.